• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Survey: Would you refer a patient overseas for treatment?

Article

Take this MedPage Today survey on medical tourism.

So-called medical tourism is a growing phenomenon. Americans by the tens of thousands are heading overseas for low prices on everything from cosmetic procedures to organ transplants and experimental stem-cell therapy. (See Americans Gamble on Bargain Surgery Abroad)

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss

Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss

Sydney Jennings
December 19th 2025
Article

Topline Phase 3 ATTAIN-MAINTAIN data show oral orforglipron met primary and key secondary endpoints for weight maintenance after prior GLP-1–based injectable therapy in adults with obesity.

Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights

Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights

Sydney Jennings
November 19th 2025
Podcast

Topics include new findings on oral acromegaly therapy, alcohol and dementia risk, tirzepatide in youth T2D, precision mood care, and LARC outcomes.

When Daily Oral PrEP Is Not the Best Fit: Lessons From Clinical Practice

When Daily Oral PrEP Is Not the Best Fit: Lessons From Clinical Practice

Kevin Hatfield, MD;Sydney Jennings
December 19th 2025
Article

Real-world patient cases illustrating how pill burden, privacy, and individual preferences influence PrEP selection and adherence.

Weekly Dose Podcast: New Insights on Colonoscopy Adherence, rt-CGM in GDM, Semaglutide Effects, Parent Vaccine Views, and MI Causes

Weekly Dose Podcast: New Insights on Colonoscopy Adherence, rt-CGM in GDM, Semaglutide Effects, Parent Vaccine Views, and MI Causes

Sydney Jennings
November 13th 2025
Podcast

Topics include rideshare support for colonoscopy, rt-CGM benefits in GDM, semaglutide and food noise, vaccine views, and MI etiology.

Tezepelumab Achieves Dual Benefit in Adults with Severe Asthma: Daily Dose / Image credit: ©New Africa/AdobeStock

Tezepelumab Achieves Dual Benefit in Adults with Severe Asthma: Daily Dose

Sydney Jennings
December 18th 2025
Article

Your daily dose of the clinical news you may have missed.

FDA Approves Lerodalcibep, Third-Generation PCSK9 Inhibitor to Treat Hypercholesterolemia, Including HeFH / image credit ©waldenmarus/stock.adobe.com

FDA Approves Lerodalcibep, Third-Generation PCSK9 Inhibitor, to Treat Hypercholesterolemia, Including HeFH

Grace Halsey
December 18th 2025
Article

Phase 3 LIBerate data showed sustained LDL-C reductions of 60% or more in high-risk patients and 50% or more in HeFH, with once-monthly self-administration.

© 2025 MJH Life Sciences

All rights reserved.